🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are
#OncoAlert
🚨
Prof. José Baselga has passed on March 21st
Dr.Baselga was an amazing oncologist& researcher who paved the way for many molecular targeted therapies
in2017 was awarded the
@myESMO
Lifetime Achievement Award
Huge loss for the Oncology Community
Our thoughts are with his family
Colleagues
In Response to the invasion of Ukraine🇺🇦, the
@OncoAlert
🚨network will be pulling out of ALL collaborations & congresses in Russia
We're non political, but we must take a stand against the injustices & aggression being directed towards Ukraine‼️
Best,
The Network🌐
The OncoAlert Network has ZERO tolerance for sexual harassment or abuse of any type & stand by our values. These kinds of actions are inexcusable and we condemn them wholeheartedly!!
Sincerely,
The OncoAlert Network
Dear friends
An Amazing way to start
#ESMO21
Our biggest heartfelt CONGRATULATIONS to the Heart & Soul of your
@OncoAlert
network
@DrChoueiri
who has just been named a GIANT of
#Cancer
care
@GiantsofCC
@GCCAwards
We are SO PROUD & congratulate him on this well deserved award!
New guidelines alert🚨
The 2024 EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines for
#ProstateCancer
offer personalized recommendations for screening, diagnosis, and treatment based on the latest data.
Emphasizing risk-adapted approaches and advanced imaging, these guidelines reflect
Corticosteroids for Immune-Related Adverse Events and Checkpoint Inhibitor Efficacy: Analysis of Six Clinical Trials out on
@JCO_ASCO
Study investigates the impact of immunosuppressive treatment💊 on survival in patients with various tumor types receiving anti–PD-1 +
WOW,
What a way to Spend our BIRTHDAY
THANK YOU DEAR COLLEAGUES
Our Solidarity and Power of community never ceases to AMAZE ME!!!
WE ARE ALL
@OncoAlert
🚨 and WE ARE BACK‼️
My Sincere Gratitude,
@weoncologists
🤠
SPECIAL⭐️
@OncoAlert
🚨NEWSLETTER
#WCLC23
World Conference🫁
#LungCancer
🇸🇬
TO GET IT REGISTER AT:
✅FLAURA2⃣
✅MARS2⃣🪐
✅TMN Staging🔬
✅DESTINY LUNG0⃣2⃣
✅Herthena🫁
✅TRIDENT🔱
✅EVOKE
✅ISABR☢️
✅RIOT🪖
and more
A great way to catch up on all the
Our warmest congratulations to the heart & Soul of our
@OncoAlert
🚨Network on being elected to the ESMO nomination Committee‼️
All for one ⚔️ One for All
Dear Colleagues
After a fantastic ESMO, we are proud to release the COMPLETE WRAP UP 🚨Newsletter for
#ESMO23
Comes out 10/26/2023 ‼️
REGISTER at TO RECEIVE IT
Covering:
✅TROPION LUNG01🫁
#LCSM
#NSCLC
✅MARIPOSA🦋
✅KEYNOTE681🔑
✅TROPION BREAST01
The OncoAlert Network🚨 is pleased to present its collective expert view on the PROSPECT clinical trial for rectal cancer presented at
#ASCO23
As a leading source of timely and reliable information in oncology, we are honored to contribute our consensus opinion on this study. In
HUGE Rounds of Congratulations to our AMAZING
@OncoAlert
🚨Colleague
@neerajaiims
👨⚕️🇺🇸 On being named “Editor in Chief” of the
@ASCO_pubs
@ASCO
Daily News📰
An amazing Colleague, Person & friend‼️
Congrats Neeraj from your
#OncoAlert
family🌐
Just out on
@NEJM
FLAURA2⃣
Phase 3⃣ trial, first-line treatment with osimertinib in combination with chemotherapy 🧪significantly extended progression-free survival in 🧬EGFR-mutated advanced non-small-cell lung cancer 🫁patients compared to osimertinib monotherapy, with higher
In just about5️⃣days
We are on site in Paris France 🇫🇷
Looking forward to a Great
#ESMO22
#EONS15
& meeting wonderful colleagues from around the globe🌐
We are ALL
@OncoAlert
🚨
A warm welcome to the
#OncoAlert5k
at
#ESMO24
!! 🏃♀️ a happy healthy way to start our week in Barcelona 🇪🇸
Huge thanks to Bayer for the Sponsorship of 5 NEW OncoAlert Catalyst Fellowships for colleagues from LMIC’s
Apply now!!
Dear Colleagues,
A warm round of applause to all of those who were chosen at the
@ASCO
elections 🗳️
Special Kudos to Dr. Robin Zon Elected ASCO President for 2024-2025 & our
@OncoAlert
🚨 faculty/friend/colleague
@montypal
of
@cityofhope
who enters the nominating committee ‼️
The OncoAlert Network is proud to announce a special collaboration with
#SABCS23
‼️
Follow OncoAlert 🚨and the San Antonio Breast Cancer Symposium accounts for up to the minute information coming from San Antonio🇺🇸
@AACR
#BreastCancer
December 5-9, 2023
San Antonio, Texas
Friends
#ASCO21
is around the corner & your
@OncoAlert
🚨faculty has you covered‼️
We'll release our TOP🔟 picks of abstracts divided by tumour group May2⃣3⃣, 2021
Just another way
#OncoAlert
🌐makes it easier for colleagues WorldWide to follow the Great Science🧬at
@ASCO
‼️
NEWS FROM INDUSTRY
Results from the DESTINY-Breast06 trial indicate that trastuzumab deruxtecan🧪could become a new standard of care for
#HER2
-low 🧬and HER2-ultralow metastatic
#BreastCancer
patients
➡️showing significant PFS improvements 📈over standard chemotherapy after
BEYOND PROUD OF OUR SCANDINAVIAN COLLEAGUES 🇸🇪 🇩🇰 SENOMAC
Omitting Axillary dissection in
#BreastCancer
w SN mets out on
@NEJM
In this noninferiority trial conducted between January 2015 and December 2021 across five countries, 2766 patients with clinically node-negative
Just out on
@TheLancetOncol
The Phase3 SENOMAC🇸🇪Trial in
#BreastCancer
Completion axillary lymph node dissection for the identification of pN2–3 status as an indication for adjuvant CDK4/6 inhibitor treatment: a post-hoc analysis of the randomised, phase 3 SENOMAC trial
In
Out on
@ASCO
Daily News📰
In the US🇺🇸women make up more than 5️⃣0️⃣% of incoming med students
What message do we send if a look at academic leadership finds women comprise 1️⃣6️⃣% of the medical school deans & only1️⃣5️⃣% of the med school department chairs‼️
Dear friends
Announcing our
@myESMO
@OncoAlert
🚨collaboration Survey on:
"Social Media & Virtual Meetings in the
#COVID19
Era".
It takes5⃣min&aims to understand how to better serve colleagues during these times
Thanks for participating
@weoncologists
Dear Friends,
Happy
#InternationalWomensDay2023
As a woman♀️you have achieved so much and paved the way for future generations‼️
To our female colleagues in healthcare👩⚕️
Your work and achievements have made you a trailblazer in your own right🩺
To our female advocates and
The
@OncoAlert
🚨network is collaborating with
@myESMO
on a survey to evaluate how
#oncology
professionals🧑⚕️👩⚕️are affected by challenges during this
#COVID19
🦠pandemic. Assessing changes to practices & well-being. We kindly request your participation‼️
OncoAlert🚨to help displaced Ukrainian🇺🇦oncology colleagues🩺has created the
#OncoAlert
Ambassador Programme
Through our resources we want to help colleagues🇺🇦on where to work as oncologists🥼or
#cancer
researchers🔬if they are refugees in these countries‼️
#StandWithUkriane
The FINAL Stats for
#ESMO22
1⃣2⃣7⃣.5⃣ Million Impressions‼️
OncoAlert Account🚨Responsible for2⃣2⃣% of those impressions🌐
Our Faculty7⃣0⃣% of the Top influences
OncoAlert REMAINS
THE MOST INFLUENTIAL in the congress4⃣Days running‼️
For Colleagues.....By Colleagues⚕️
#ESMO23
Dear Friends,
The
@OncoAlert
🚨network would like to wish good luck to All candidates in the
@ASCO
elections and would like to wish an extra bit of luck and send our heartfelt congratulations to our friend &
@OncoAlert
GU faculty member
@montypal
from
@cityofhope
‼️
Kudos🙌
Out on
@JAMA_current
🚨
Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer
In patients with early-stage Triple Negative
#BreastCancer
who did not undergo adjuvant or neoadjuvant chemotherapy🧪
➡️breast cancer tissue with a higher abundance of TIL levels was
Lung
#cancer
🫁is the 2⃣nd most commonly diagnosed cancer worldwide.
In the US🇺🇸
#NSCLC
accounts for 8⃣1⃣% of cases. 238,340 US adults will be diagnosed in 2023. Worldwide, 2,206,771 cases were reported in 2020.
Let's unite to fight
#LungCancer
, support patients, and continue
It's Official‼️
@SABCSSanAntonio
and your
@OncoAlert
🚨Network are Officially involved in a Special Collaboration during the
#SABCS22
🌐
Stay tuned for all the Great
#BreastCancer
Science coming out of the congress w/ this joint initiative!
We Are All OncoAlert🚨
Dear colleagues,
It is an honor to announce a remarkable collaboration between The
@OncoAlert
🚨Network,
@CD_AACR
and The
#AACR23
Meeting‼️
This special collaboration has been carefully crafted to enrich and enhance the experience of all attendees of the
@AACR
🇺🇸meeting and
Our Warmest congratulations to one of our Founding Members, 4⃣Time
@OncoAlert
🚨Colloquium faculty and great friend
@hoperugo
🇺🇸 who will receive the
@myESMO
#ESMOBreast24
Award in Berlin this MAY in recognition of her exceptional contributions to
#BreastCancer
clinical research
Just out on
@TheLancetOncol
by our
@partners
at
@CancerCareMASCC
guidelines for Prevention & mgt of
ACUTE RADIATION ☢️DERMATITIS
Delphi consensus process involving international experts identified evidence-based interventions, including:
✅photobiomodulation therapy
✅Mepitel
Dear friends,
A very warm Happy Birthday 🎂 to our
@OncoAlert
🚨colleague &
@myESMO
president
@peters_solange
👩🏼⚕️🇨🇭
Wishing her the best on her day‼️
Best from her OncoAlert family🌐
Our warmest Congratulations to our friend
@jsoriamd
🇫🇷as he joins
@Amgen
to lead the oncology therapeutic area as senior vice president‼️
Kudos & best from the
@OncoAlert
🚨family🌐
Dear Colleagues,
We are pleased to announce our
@OncoAlert
recommendations abstracts presented in
#ASCO19
.Our
#lungcancer
& H&N
#Oncologists
have developed these lists as an aid to navigating the congress. We hope you enjoy them & see you at ASCO!
Best regards,
@weoncologists
Friends,
The
@OncoAlert
🚨Network Congratulates The Heart & Soul of our Family🌐
@DrChoueiri
👨⚕️🇺🇸on this incredible upcoming plenary presentation LBA5 at
#ASCO21
‼️
Yet Another reason to look forward to
@ASCO
🔬🧬Save the Date‼️
Best,
@weoncologists
🤠
Dear Colleagues,
We are pleased to announce our
@OncoAlert
recommendations abstracts presented in
#ASCO19
.Our
#Genitourinary
#Oncologists
have developed these lists as an aid to navigating the congress. We hope you enjoy them & see you at ASCO!
Best regards,
@weoncologists
News Direct from Industry:
"KEYNOTE 522 meets OS Endpoint in High Risk Early Stage TNBC
#BreastCancer
"
"New OS results build on the pathological complete response and event-free survival data previously reported from the KEYNOTE-522 trial"
" KEYNOTE522: Pembrolizumab in
Dear friends
An honour to present
@ErikaHamilton9
who discusses DESTINY Breast-03 just seen at
#ESMO21
T-DXd vs T-DM1⃣ in HER2+ metastatic
#BreastCancer
✅PFS in favor of T-DXd vs T-DM1
✅Better 12m OS in favor of T-DXd
✅Strong trend to OS superiority
best,
@weoncologists
Beyond sad to hear about the passing of our wonderful
@OncoAlert
🚨Colleague
@Kamacintosh
🇨🇦
A fierce & selfless
#LungCancer
patient advocate, who will be deeply missed!
Our thoughts go out to her family and loved ones, rest in peace Kim
#LCSM
Dear friends🌐
This
#ESMO21
you can expect Daily RoundUps from
@OncoAlert
🚨&
@ecancer
on the TOP News happening on the
@myESMO
Congress the day before & other great initiatives
Thanking you for the wonderful support & hope you enjoy this amazing ESMO‼️
Best,
@weoncologists
🤠
The
@OncoAlert
🚨Network Proudly announces its 3⃣rd Rising star⭐️Recipient
Warm congratulations to
@ZiadBakouny
of
@DanaFarber
for his great work & accomplishments! We will be highlighting his work in the next coming weeks.
Dr. Bakouny was nominated by his mentor,
@DrChoueiri
Dear Colleagues
@OncoAlert
🚨Proudly Presents our
#ESMO23
initiatives done in collaboration with our partners and dedicated faculty, all geared towards sharing the remarkable science out of Madrid🇪🇸
📰The OncoAlert Daily Newsletter at ESMO23:
REGISTER AT
Just Out in the RED journal
@ASTRO_org
🇺🇸
The POP-RT trial 🇮🇳found that whole pelvic radiotherapy ☢️for high/very high-risk
#ProstateCancer
:
➡️resulted in comparable long-term urinary toxicity and quality of life to prostate-only radiotherapy, with no identified significant